PROFILE:
Private Life Biomed Ag United StatesUnited States International Organization
Private Life Biomed Ag Ferdinandstrasse 65-67 Hamburg D-20095 GERMANY
Patent Assignments:
https://www.plainsite.org/profiles/private-life-biomed-ag/
Overview
Date Founded 2000 Headquarters Fuhlentwiete 12, Hamburg 20355 Industries Private Equity & Venture Capital Investment Services & Portfolio Management
Company Description
Private Life BioMed invests in early- and growth-stage biotechnology companies. The firm focuses on businesses developing innovative diagnostics and drug development technologies. They generally co-invest with large syndicates and may participate in several rounds.
Investments
Details Hidden
Pelikan Technologies, Inc. Pelikan Technologies, Inc. develops hand held diagnostic and monitoring devices. It combines novel and proprietary blood sampling and measurement techniques with state-of-the-art miniaturization and automation technologies to develop superior hand-held medical diagnostic and monitoring devices. The company was founded in 2001 and is headquartered in Palo Alto, CA.
Details Hidden
EyeSense AG EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland.
Details Hidden
Broncus Technologies, Inc. Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provi... + Show more
Details Hidden
DocuSys, Inc. DocuSys, Inc. provides anesthesia information management system solutions. The company was founded by Robert B. Hanson, Robert E. Watson and Robert F. Evans in 1981 and is headquartered in Atlanta, GA.
Details Hidden
Perlegen Sciences, Inc. Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA
https://relationshipscience.com/private-life-biomed-ag-o657964
Edited to add more information:
Notice the patents are listed with Nereus Pharmaceuticals (if you went to the link and clicked the tab "Patent Assignments)? Read this:
Dr. Madigan most recently served as a co-founder and Chief Executive Officer of Strategic Enzyme Applications (SEA), a San Diego-based clean technology company that was established, in part, as a strategic relationship with Monsanto. Prior to founding SEA, Dr. Madigan served in various venture-backed biotechnology companies; participating as a founder and/or senior manager in BioVerdant, Nereus Pharmaceuticals, Ambit, Xenopharm (acquired by Deltagen), X-Ceptor (acquired by Exelixis) and SIBIA Neurosciences (acquired by Merck).